SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 24, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago
Insider cluster: 3 insiders, $3.5M total
Actionable Insight • Neutral

This insider cluster is routine and non-material. No trading action warranted. Monitor for any upcoming SEC filings or clinical/regulatory updates for the company.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$566.99
T+0 close · Apr 24, 2026 · via day close
Latest settled
−6.61%
T+60 · $529.53
Vs SPY
−9.82%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $566.99entry
  2. T+1 · 7mo ago +0.37%α +0.86% · $569.11
  3. T+5 · 7mo ago +2.51%α +2.11% · $581.22
  4. T+20 · 6mo ago +2.02%α −2.94% · $578.43
  5. T+60 · 4mo ago −6.61%α −9.82% · $529.53
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three insiders at United Therapeutics (UTHR), including the CEO and CFO, sold a total of ~$3.48M in stock over a five-day period. All sales were preceded by derivative exercises (stock options) and represent routine cash-out transactions. At $24.9B market cap, the total sales are negligible (0.014% of market cap), carrying no material signal.

Key Financial Metrics

Direction
selling
Total Value
$3.5M
Insiders
3

Key Facts

  • CEO Martine Rothblatt sold 2,306 shares for ~$1.1M across multiple days.
  • CFO James Edgemond sold 1,716 shares for ~$971K.
  • Director Christopher Patusky sold 2,910 shares for ~$1.66M.
  • All sales were accompanied by stock option exercises at $0 or near-market prices.
  • Total open-market sales of ~$3.48M represent 0.014% of UTHR's $24.9B market cap.

Financial Impact

Total insider selling of $3.48M, immaterial relative to $24.9B market cap.

dilutioninsider ownership

Risk Factors

  • No material risks identified from this insider activity.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1777494766335

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026